THC Farmaceuticals Receives Patent Protection in Republic of South Africa For Methods of Producing Antibody- Rich Cannabis and Honeysuckle Plants

THOUSAND OAKS, CA / ACCESSWIRE / June 12, 2019 / CBDual Biotechnology Corp., a subsidiary of THC Farmaceuticals, Inc (OTC PINK: CBDG) today announced that its parent company has been granted patent protection for the South African Patent Application No. 2017/01966 regarding the parent company’s Methods of Producing Antibody- Rich Cannabis and Honeysuckle Plants. South African Republic’s Patent Office has scheduled publication of this international...

Continue reading

USAID Taps Cornell to Advance Ebola Protective Garments

In the war against Ebola, Cornell University – along with partners International Personnel Protection Inc. (IPP) and protective apparel manufacturer Kappler Inc. – will rethink, reimagine and re-engineer protective suits for health care workers on the front lines battling the life-threatening contagion. The garments – made possible through a U.S. Agency for International Development (USAID) grant – will be more comfortable and breathable, with...

Continue reading

North Korea lifts Ebola caused travel ban

North Korea has lifted severe restrictions on foreign travel it imposed last year to keep the Ebola virus from crossing its borders, although North Korea is thousands of miles from the Ebola outbreak in West Africa. The already isolated country virtually closed its borders to foreigners last October, halting all non-essential visas and requiring those few foreigners allowed in to undergo three weeks of quarantine. The rules applied to diplomats,...

Continue reading

Fujifilm’s Flu Drug Turned Ebola Drug Avigan Proven Effective

Fujifilm Holdings Corp.’s drug Avigan, which has shown signs of efficacy against the Ebola virus, has drawn interest from about 20 countries and the company stands ready for large orders, its chief executive said. “We can provide as much as we are asked for,” said Shigetaka Komori in an interview Friday. The company has enough of the drug’s basic ingredient on hand to manufacture pills for 300,000 people and will ramp up production if necessary,...

Continue reading

Could Cannabis Be a Cure for Ebola?

There have been many people suggesting that Cannabis can treat and even cure Ebola. While there is no scientific evidence to back up such claims… Cannabis can be used to treat a variety of illnesses such as: HIV and AIDS Alzheimer’s Arthritis Asthma Crohn’s Disease Epilepsy and Seizures Glaucoma Hepatitis C Migraines Multiple Sclerosis  Nausea from Chemotherapy Pain Some Psychological Conditions Tourette Syndrome Those that...

Continue reading

Ebola Drugs Could be Obsolete Before They’re Available

New treatments for Ebola could be obsolete before they are available for use by patients, because of genetic mutations in the disease, scientists have warned. They said they’d found 10 new mutations that might interfere with how three of the most advanced drugs work against Ebola. The drugs, including the experimental ZMapp given to several Ebola survivors, should be tested against the current strain, the researchers said. Experimental drugs...

Continue reading

Ebola vaccine gets $115M to speed development

Johnson & Johnson said on Friday that newly formed groups supporting work on its experimental Ebola vaccine would receive 100 million euros ($115 million) from Europe’s Innovative Medicines Initiative to speed development. The U.S. drug maker earlier this month announced it had started clinical trials of its two-injection vaccine, which uses a booster from Denmark’sBavarian Nordic, making it the third such product to enter human...

Continue reading

New thermometer helps doctors more safely diagnose Ebola

Recent headlines have put a spotlight on the dangers of diagnosing and treating Ebola. Contact with victims of the deadly disease has left several medical professionals with symptoms of their own. Visiomed, a 90-person medical device company founded in France in 2007, is trying to reduce that danger. It has developed a thermometer, called ThermoFlash, that doesn’t require touching the patient. That eliminates the threat of a doctor contracting...

Continue reading

Johnson & Johnson starts Ebola Vaccine trial

The first of 72 healthy volunteers have already received the initial dose of a drug researchers hope could put an end to the worst Ebola outbreak in the history. Janssen Pharmaceutical Companies, owned byJohnson & Johnson (JNJ), is developing the ebola vaccine together with Bavarian Nordic. The company said it could begin large scale trials by May, and make 2 million vaccinations available later this year. The drug does not contain the virus...

Continue reading

Aethlon Medical announces approval of revolutionary Ebola treatment

SAN DIEGO, PRNewswire/ — Aethlon Medical, Inc. (AEMD), the pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, today announced that the United States Food and Drug Administration (FDA) has approved a clinical protocol to treat Ebola-infected individuals in the U.S. with the Aethlon Hemopurifier®. In the treatment of viral pathogens, the Hemopurifier® is a first-in-class bio-filtration device designed...

Continue reading